We are pleased to announce a new partnership between Serum Life Science Europe GmbH (SLS Europe) and INCATE (INCubator for Antibacterial Therapies Europe) in the ongoing battle against antimicrobial resistance (AMR).
At SLS Europe, we have been dedicated to advancing pharmaceutical products since our inception in 2002. Now, we’re joining forces with INCATE, a leading initiative focused on addressing the global challenge of AMR.
INCATE is a partnership between the founding members, bringing together translational and basic research, industry experts, entrepreneurs, and investors from across Europe and beyond.
Through this partnership, SLS Europe will leverage its expertise and experience to contribute significantly to the fight against AMR. With our track record in pharmaceutical development, we are uniquely positioned to make a meaningful impact in this critical healthcare challenge.
Together with INCATE, we aim to foster innovation, empower early-stage developers, and drive tangible progress in the fight against antimicrobial resistance. We’re excited about the possibilities this partnership brings and look forward to the positive impact we can make together.
Our shared mission is clear: to accelerate the development of new therapies, diagnostics, and interventions to combat AMR.
For more information about SLS Europe and our partnership with INCATE, please visit our websites (sls-eu.com and incate.net) or contact us directly. Together, let’s combat antimicrobial resistance and build a healthier world.
